LH
Labcorp Holdings Inc. NYSE Listed Mar 29, 1990$258.04
After hrs
$254.98
-0.04%
Mkt Cap $21.2B
52w Low $239.67
34.0% of range
52w High $293.72
50d MA $268.49
200d MA $268.81
P/E (TTM)
24.3x
EV/EBITDA
13.7x
P/B
2.5x
Debt/Equity
0.8x
ROE
10.2%
P/FCF
17.3x
RSI (14)
—
ATR (14)
—
Beta
0.98
50d MA
$268.49
200d MA
$268.81
Avg Volume
640.4K
Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
358 South Main Street · Burlington, NC 27215 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | BMO | 4.09 | 4.25 | +3.9% | 257.14 | +2.9% | -0.1% | -0.4% | -1.1% | +1.6% | -0.1% | — |
| Feb 17, 2026 | BMO | 3.95 | 4.07 | +3.0% | 282.63 | -1.7% | -2.1% | +0.8% | +1.3% | +0.1% | +0.9% | — |
| Oct 28, 2025 | BMO | 4.13 | 4.18 | +1.2% | 275.66 | -3.9% | -5.8% | -4.4% | +1.7% | +0.6% | +1.5% | — |
| Jul 24, 2025 | BMO | 4.17 | 4.35 | +4.3% | 250.51 | +6.4% | +6.9% | -1.0% | -1.2% | -0.1% | +0.8% | — |
| Apr 29, 2025 | BMO | 3.74 | 3.84 | +2.7% | 229.60 | -3.4% | +4.7% | +0.2% | +0.1% | +2.6% | -0.3% | — |
| Feb 6, 2025 | BMO | 3.39 | 3.45 | +1.8% | 249.99 | +1.2% | -0.9% | -0.6% | -0.5% | +0.0% | -1.6% | — |
| Oct 24, 2024 | BMO | 3.47 | 3.50 | +0.9% | 219.90 | +2.6% | +4.6% | -0.6% | -0.5% | +0.3% | +1.1% | — |
| Aug 1, 2024 | BMO | 3.78 | 3.94 | +4.2% | 215.44 | +2.1% | +8.3% | +1.1% | -3.1% | -1.2% | -2.9% | — |
| Apr 25, 2024 | BMO | 3.48 | 3.68 | +5.7% | 207.94 | -1.5% | -4.6% | +0.0% | +2.9% | -1.4% | -0.0% | — |
| Feb 15, 2024 | BMO | 3.29 | 3.30 | +0.3% | 228.11 | -0.5% | -2.6% | -2.5% | -0.4% | +1.0% | -0.1% | — |
| Oct 26, 2023 | BMO | 3.37 | 3.38 | +0.3% | 197.69 | +0.9% | +4.2% | -3.4% | -0.4% | +0.8% | +2.1% | — |
| Jul 27, 2023 | BMO | 3.47 | 3.42 | -1.4% | 218.84 | -1.7% | -1.3% | -0.7% | -0.3% | -0.1% | +0.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 8 | Evercore ISI | Maintains | Outperform → Outperform | — | $269.17 | $271.95 | +1.0% | +2.1% | -0.5% | -4.5% | +1.2% | +1.8% |
| Feb 24 | Piper Sandler | Maintains | Neutral → Neutral | — | $285.30 | $285.20 | -0.0% | +0.6% | -1.5% | +1.7% | +0.5% | -0.9% |
| Feb 18 | Baird | Maintains | Outperform → Outperform | — | $276.67 | $279.37 | +1.0% | +0.8% | +1.3% | +0.1% | +0.9% | +0.6% |
| Feb 18 | JP Morgan | Maintains | Overweight → Overweight | — | $276.67 | $279.37 | +1.0% | +0.8% | +1.3% | +0.1% | +0.9% | +0.6% |
| Feb 6 | JP Morgan | Maintains | Overweight → Overweight | — | $278.23 | $280.00 | +0.6% | -0.4% | -1.2% | +3.8% | +1.9% | -4.1% |
| Nov 7 | JP Morgan | Maintains | Overweight → Overweight | — | $246.64 | $246.84 | +0.1% | +2.5% | +3.3% | +2.7% | -0.8% | +0.7% |
| Oct 29 | UBS | Maintains | Buy → Buy | — | $259.69 | $259.00 | -0.3% | -4.4% | +1.7% | +0.6% | +1.5% | -2.1% |
| Oct 17 | Mizuho | Maintains | Outperform → Outperform | — | $283.71 | $284.68 | +0.3% | +0.8% | +1.7% | -2.3% | -0.5% | +0.4% |
| Oct 17 | UBS | Maintains | Buy → Buy | — | $283.71 | $284.68 | +0.3% | +0.8% | +1.7% | -2.3% | -0.5% | +0.4% |
| Oct 3 | Evercore ISI | Maintains | Outperform → Outperform | — | $279.44 | $279.96 | +0.2% | -0.9% | -0.7% | +1.7% | -0.8% | +0.1% |
| Oct 2 | Barclays | Maintains | Equal Weight → Equal Weight | — | $279.06 | $277.84 | -0.4% | +0.1% | -0.9% | -0.7% | +1.7% | -0.8% |
| Jul 25 | Evercore ISI | Maintains | Outperform → Outperform | — | $267.69 | $268.04 | +0.1% | -1.0% | -1.2% | -0.1% | +0.8% | -1.5% |
| Jul 25 | UBS | Maintains | Buy → Buy | — | $267.69 | $268.04 | +0.1% | -1.0% | -1.2% | -0.1% | +0.8% | -1.5% |
| Jul 25 | Truist | Maintains | Buy → Buy | — | $267.69 | $268.04 | +0.1% | -1.0% | -1.2% | -0.1% | +0.8% | -1.5% |
| Jul 25 | Baird | Maintains | Outperform → Outperform | — | $267.69 | $268.04 | +0.1% | -1.0% | -1.2% | -0.1% | +0.8% | -1.5% |
| Jul 25 | Morgan Stanley | Maintains | Overweight → Overweight | — | $267.69 | $268.04 | +0.1% | -1.0% | -1.2% | -0.1% | +0.8% | -1.5% |
| Jul 18 | UBS | Maintains | Buy → Buy | — | $247.24 | $247.82 | +0.2% | -1.4% | -0.3% | +3.7% | -0.6% | +6.9% |
| Jul 9 | Evercore ISI | Maintains | Outperform → Outperform | — | $257.45 | $260.01 | +1.0% | +0.6% | -2.1% | -1.6% | +0.1% | -1.7% |
| Jun 25 | Barclays | Maintains | Equal Weight → Equal Weight | — | $262.53 | $261.73 | -0.3% | -1.5% | -0.7% | +1.4% | +0.7% | +0.7% |
| Jun 11 | Morgan Stanley | Maintains | Overweight → Overweight | — | $259.37 | $260.00 | +0.2% | +0.2% | +0.7% | -0.2% | +1.1% | -1.7% |
| May 12 | Truist | Maintains | Buy → Buy | — | $245.73 | $248.73 | +1.2% | +2.1% | -0.4% | -3.1% | +1.6% | +1.3% |
| May 6 | Piper Sandler | Maintains | Neutral → Neutral | — | $246.82 | $245.05 | -0.7% | -1.2% | +0.8% | +1.2% | -1.2% | +2.1% |
| Apr 30 | Barclays | Maintains | Equal Weight → Equal Weight | — | $240.42 | $239.32 | -0.5% | +0.2% | +0.1% | +2.6% | -0.3% | -1.2% |
| Apr 30 | Baird | Maintains | Outperform → Outperform | — | $240.42 | $239.32 | -0.5% | +0.2% | +0.1% | +2.6% | -0.3% | -1.2% |
| Apr 11 | Truist | Maintains | Buy → Buy | — | $218.61 | $218.15 | -0.2% | +1.3% | +3.0% | -0.9% | -2.4% | -1.6% |
| Apr 10 | Barclays | Maintains | Equal Weight → Equal Weight | — | $230.48 | $228.66 | -0.8% | -5.2% | +1.3% | +3.0% | -0.9% | -2.4% |
| Mar 4 | Citigroup | Upgrade | Neutral → Buy | — | $254.04 | $257.00 | +1.2% | +1.1% | -1.0% | -0.1% | -0.4% | -3.5% |
| Feb 10 | Piper Sandler | Maintains | Neutral → Neutral | — | $246.27 | $245.67 | -0.2% | -0.5% | +0.0% | -1.6% | +1.5% | +0.7% |
| Feb 7 | Barclays | Maintains | Equal Weight → Equal Weight | — | $247.74 | $248.88 | +0.5% | -0.6% | -0.5% | +0.0% | -1.6% | +1.5% |
| Feb 6 | Jefferies | Maintains | Buy → Buy | — | $249.99 | $252.98 | +1.2% | -0.9% | -0.6% | -0.5% | +0.0% | -1.6% |
| Feb 3 | Barclays | Maintains | Equal Weight → Equal Weight | — | $249.80 | $248.22 | -0.6% | -0.8% | -0.5% | +1.3% | -0.9% | -0.6% |
| Jan 28 | UBS | Maintains | Buy → Buy | — | $249.67 | $249.59 | -0.0% | -0.5% | -0.9% | +2.2% | -0.7% | -0.8% |
| Jan 7 | Evercore ISI | Upgrade | In Line → Outperform | — | $229.92 | $232.51 | +1.1% | +2.3% | -0.3% | -1.0% | +0.9% | +0.2% |
| Dec 17 | Morgan Stanley | Maintains | Overweight → Overweight | — | $229.62 | $228.57 | -0.5% | +0.6% | -2.0% | +0.3% | +0.7% | -0.3% |
| Dec 13 | BofA Securities | Maintains | Buy → Buy | — | $231.84 | $231.35 | -0.2% | +0.1% | -1.0% | +0.6% | -2.0% | +0.3% |
| Oct 30 | HSBC | Upgrade | Hold → Buy | — | $228.09 | $229.68 | +0.7% | +1.1% | -1.0% | -0.5% | +0.0% | +0.9% |
| Oct 28 | Piper Sandler | Maintains | Neutral → Neutral | — | $228.63 | $230.25 | +0.7% | -0.5% | +0.3% | +1.1% | -1.0% | -0.5% |
| Oct 25 | Barclays | Maintains | Equal Weight → Equal Weight | — | $230.07 | $229.28 | -0.3% | -0.6% | -0.5% | +0.3% | +1.1% | -1.0% |
| Oct 25 | Baird | Maintains | Outperform → Outperform | — | $230.07 | $229.28 | -0.3% | -0.6% | -0.5% | +0.3% | +1.1% | -1.0% |
| Aug 5 | BofA Securities | Maintains | Buy → Buy | — | $236.00 | $232.00 | -1.7% | -3.1% | -1.2% | -2.9% | +2.5% | +0.8% |
| Aug 2 | Barclays | Maintains | Equal Weight → Equal Weight | — | $233.39 | $232.70 | -0.3% | +1.1% | -3.1% | -1.2% | -2.9% | +2.5% |
| Aug 2 | Baird | Maintains | Outperform → Outperform | — | $233.39 | $232.70 | -0.3% | +1.1% | -3.1% | -1.2% | -2.9% | +2.5% |
| Aug 2 | UBS | Maintains | Buy → Buy | — | $233.39 | $232.70 | -0.3% | +1.1% | -3.1% | -1.2% | -2.9% | +2.5% |
| Aug 2 | Truist | Maintains | Buy → Buy | — | $233.39 | $232.70 | -0.3% | +1.1% | -3.1% | -1.2% | -2.9% | +2.5% |
| Aug 2 | Deutsche Bank | Maintains | Hold → Hold | — | $233.39 | $232.70 | -0.3% | +1.1% | -3.1% | -1.2% | -2.9% | +2.5% |
| Jul 9 | Evercore ISI | Maintains | In Line → In Line | — | $202.96 | $201.70 | -0.6% | -1.8% | +0.5% | +2.9% | -0.0% | +0.6% |
| Jul 8 | Baird | Maintains | Outperform → Outperform | — | $204.58 | $204.00 | -0.3% | -0.8% | -1.8% | +0.5% | +2.9% | -0.0% |
| Jun 13 | Baird | Maintains | Outperform → Outperform | — | $196.36 | $195.42 | -0.5% | +0.1% | +1.7% | +0.8% | +2.5% | +0.4% |
| May 30 | JP Morgan | Maintains | Overweight → Overweight | — | $192.50 | $192.51 | +0.0% | +0.5% | +0.8% | +0.1% | +0.9% | +0.7% |
| Apr 26 | Truist | Maintains | Buy → Buy | — | $198.35 | $197.08 | -0.6% | +0.0% | +2.9% | -1.4% | -0.0% | -0.5% |
No insider trades available.
8-K
Labcorp Holdings Inc. -- 8-K Filing
Labcorp Holdings reported Q1 2026 results and raised full-year guidance, signaling confidence in its laboratory services business performance and providing updated investor expectations for 2026.
Apr 30
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
LabCorp declares a $0.72 quarterly dividend, demonstrating confidence in cash generation and shareholder returns, which typically supports stock valuation for income-focused investors.
Apr 9
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
LH scheduled Q1 2026 earnings release for April 30, 2026, signaling normal operational transparency; investors should monitor results for revenue growth and margin performance in diagnostic/laboratory services.
Mar 31
8-K · 1.01
! Medium
Unknown — 8-K 1.01: Financing / Debt Agreement
Failure to meet covenant requirements could force accelerated repayment of debt, creating liquidity risk and potentially triggering financial distress if the company cannot refinance quickly.
Mar 20
8-K
Labcorp Holdings Inc. -- 8-K Filing
Labcorp exceeded expectations in 2025 with 7% revenue growth and double-digit adjusted EPS expansion, signaling operational strength entering 2026 despite ongoing healthcare sector challenges.
Feb 17
8-K · 5.02
!!! Very High
Labcorp Holdings Inc. -- 8-K 5.02: Executive Change
Labcorp Holdings appointed John H. Sampson as director effective February 9, 2026, potentially bringing fresh expertise to the board's oversight of the clinical laboratory company's operations.
Feb 9
Data updated apr 25, 2026 7:05pm
· Source: massive.com